Latest California Healthline Stories
KHN On Call: Answers To Questions On Tax Credits, Penalties And Age Ratings
KHN and NPR answer your questions on the GOP health bill.
GOP Bill’s Unheralded Changes In Rules Could Undermine Health And Prospects Of Neediest
Lesser-known provisions in the Republican proposal to replace the Affordable Care Act would push some Medicaid enrollees out of coverage and cause financial pain for others.
Do You Speak Repeal And Replace? Click Thought Bubbles For Translations
Want to understand the complicated lingo surrounding the ongoing battle over the Affordable Care Act? We’ve got the guide for you.
On Medicaid Money, GOP Has Win-Or-Lose Proposition For States
The House Republicans’ bill to repeal Obamacare would change how the federal government allocates matching funds to state Medicaid programs — and could cost some states billions of dollars a year in federal aid.
Report: Fired U.S. Attorney Was Probing Tom Price’s Stock Trades
The HHS Secretary bought stock in companies that stood to benefit from legislation he voted for and sponsored as a Georgia congressman.
GOP’s 3-Bucket Strategy To Repeal And Replace Health Law Is Springing Leaks
Republican leaders say that to dismantle Obamacare it will take not just the bill now being debated in the House, but also regulatory changes and other bills to come later. Some party members say that plan is not realistic.
Obamacare Pushed Nonprofit Hospitals To Do Good Beyond Their Walls. Now What?
A provision in the 2010 health law required these hospitals to justify their tax exemption by demonstrating involvement in community health. Repeal, replace or repair could stall that momentum.
Health Exchange Enrollment Misses Obama Administration’s Goal, But Stays Steady
Federal officials said 12.2 million people signed up for plans this year on the health law’s marketplaces, down slightly from 2016.
Many Californians Could Be Priced Out Of Exchange Coverage, Analysis Finds
California’s health insurance exchange released an analysis showing that Republicans’ plan to trim subsidies, on average, by 40% would fall hard on elderly and very low-income people, especially in expensive areas like San Francisco.
By The Numbers: Trump’s Choice For FDA Chief Is Versatile And Entrenched In Pharma
The numbers show that President Trump’s choice for FDA commissioner, Scott Gottlieb, has long-standing ties to pharmaceutical companies as a board member or consultant and that he had to recuse himself multiple times while working at the FDA.